ArticleJournal of diabetes investigation2025

Hepatokine leukocyte cell-derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction-associated steatotic liver disease in the general population.

Keita Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.